Related Experiment Video
Updated: Jun 19, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Role of peak D-dimer in predicting mortality and venous thromboembolism in COVID-19 patients
Rachel H Lee1, Shan Wang1,2, Meredith Akerman2,3
1Department of Pharmacy, NYU Langone Hospital-Long Island, Mineola, NY, USA.
Insights
Elevated D-dimer levels in COVID-19 patients indicate higher risk for mortality and venous thromboembolism (VTE) events. This finding aids in predicting adverse outcomes for hospitalized patients.
Area of Science:
- Medical research
- Hematology
- Infectious diseases
Background:
- COVID-19 is frequently associated with elevated D-dimer levels.
- Understanding the prognostic value of D-dimer is crucial for managing severe cases.
Purpose of the Study:
- To evaluate the predictive role of D-dimer levels for mortality and venous thromboembolism (VTE) in hospitalized COVID-19 patients.
Main Methods:
- Retrospective chart review of 350 COVID-19 patients from April to June 2020.
- Analysis of peak D-dimer levels and correlation with mortality and VTE events (deep venous thrombosis, pulmonary embolism).
Main Results:
- Patients with VTE events had significantly higher peak D-dimer levels (4876 ng/ml) compared to the non-VTE group (680 ng/ml).
- Deceased patients exhibited higher peak D-dimer levels (4690 ng/ml) than survivors (501 ng/ml).
- Optimal D-dimer cutoffs identified: 1437 ng/ml for VTE prediction (84.2% sensitivity, 65.0% specificity) and 2004 ng/ml for mortality prediction (71.0% sensitivity, 77.9% specificity).
Conclusions:
- Elevated D-dimer levels in hospitalized COVID-19 patients are significant indicators of mortality risk.
- D-dimer levels can serve as a valuable biomarker for predicting venous thromboembolism events in COVID-19 patients.
Abstract:
Covid 19 patients often present with elevated D-dimer levels. The purpose of this study is to evaluate the role of D-Dimer levels in Covid 19 patients to predict mortality and venous thromboembolism (VTE) events. This is a retrospective chart review study from 1 April 2020 to 30 June 2020, during the peak Covid pandemic. A total of 350 patients were enrolled in this study; 69 (19.7%) patients died; 12 (3.4%) had a deep venous thrombosis; and 8 (2.3%) had a pulmonary embolism outcome. Peak D-dimer levels were collected with median levels of 765 ng/ml (266, 3135). Patients with VTE outcomes had significantly higher levels of peak D-dimers than patients in the non-VTE group (4876 vs 680, p < 0.0001). Patients who died had higher peak D-dimer levels than those who survived (4690 vs 501, p < 0.0001). The optimal cutoff point in peak D-dimer in predicting VTE events was 1437, yielding a sensitivity of 84.2% and a specificity of 65.0%. The optimal cutoff point in peak D-dimer in predicting mortality was 2004, yielding a sensitivity of 71.0% and a specificity of 77.9%. This study suggests that D-dimer levels can be elevated in Covid 19 hospitalized patients and can serve as indicators for mortality and VTE events.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction

